Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 10/20 | 0.43 |
| ▸ | MTOR | P42345 | 10/20 | 0.43 |
| ▸ | PIK3CG | P48736 | 10/20 | 0.43 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 4/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8177669 | 0.83 | PIK3CA (0.41) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3427707 | 0.82 | PIK3CA (0.50) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3429722 | 0.82 | ALDH1A1 (0.43) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3429006 | 0.81 | PIK3CA (0.45) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3428987 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3428738 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3430205 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3429949 | 0.77 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3429479 | 0.76 | ALDH1A1 (0.43) | ALDH1A1KDM4EGAAPIK3CAMTOR | |
| SCHEMBL3408187 | 0.76 | PIK3CA (0.59) | ALDH1A1KDM4EGAAPIK3CAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090181963-A1 | 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES | WYETH (US) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181963-A1 | 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES | MTOR, PIK3CA, PIK3CD | ALDH1A1 3181/4885KDM4E 1194/4885GAA 2628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.